Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026986 (
myelodysplastic syndrome
)
14,926
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The transcription factor ecotropic viral integration site 1 (Evi1) is associated with acute myeloid leukemia (AML) and
myelodysplastic syndrome
(
MDS
) in patients due to chromosomal aberration of chromosome 3. Here we show that Evi1 interacts with the histone methyltransferase
SUV39H1
. The interaction requires the N-terminal part of Evi1 and the H3-specific histone methyltransferase domain, SET, of
SUV39H1
without Evi1 having an inhibitory effect on
SUV39H1
methyltransferase activity. Presence of
SUV39H1
enhances Evi1 transcriptional repression in a dose dependent manner. In addition, Evi1 also interacts with another histone methyltransferase, G9a, but not with SET9. Our data establish an epigenetic role of Evi1 in cell transformation by recruiting higher order chromatin remodeling complexes.
...
PMID:A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a. 1861 62
EVI1 is an oncoprotein inappropriately expressed in acute myeloid leukemia and
myelodysplastic syndrome
cells. In vitro studies indicate that diverse biological properties can be attributed to this protein. Its role in leukemogenesis is still unclear but it is thought that overall EVI1 can act mostly as a transcription repressor through its interaction with a subset of histone deacetylases. Studies with histone deacetylase inhibitors have however indicated that EVI1-mediated repression can be only partially rescued by deacetylase inhibitor drugs, suggesting that additional chromosomal modifications might occur to induce gene repression by EVI1. To investigate whether histone methylation contributes to the repressive potential of EVI1, we examined a potential association between EVI1, the histone methyltransferase (HMT)
SUV39H1
, and methyltransferase activity in vitro. We find that EVI1 directly interacts with
SUV39H1
and that the proteins form an active complex with methyltransferase activity in vitro. Our data indicate that
SUV39H1
enhances the transcription repressive potential of EVI1 in vivo. We suggest that EVI1 affects promoters' activity in two different pathways, by association with histone deacetylases and by recruiting chromatin-modifying enzymes to impose a heterochromatin-like structure establishing a lasting transcription repression.
...
PMID:EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression. 1865 52